Pharmacoepidemiological Analysis of Provincial Differences between Consumption of Macrolides and Rates of Erythromycin Resistance among Streptococcus pyogenes Isolates in Spain
Open Access
- 1 August 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (8), 2959-2963
- https://doi.org/10.1128/jcm.40.8.2959-2963.2002
Abstract
The M phenotype is by far the most common mechanism of erythromycin resistance among Streptococcus pyogenes isolates in Spain. A geographic analysis of the relationship between within-country differences in the prevalence of M-type resistance to erythromycin in S. pyogenes and the level of consumption of 14- and 15-membered macrolides within different provinces was carried out. From 1998 to 1999, a nationwide multicenter surveillance study yielded 2,039 consecutive pharyngeal isolates of S. pyogenes . Data on antibiotic consumption for the same period were gathered from IMS Health, and the corresponding daily defined doses per 1,000 inhabitants per day were calculated according to the Anatomic Therapeutic Classification index. Macrolide use was subdivided into dosages given three times a day (TID), twice a day (BID), or once a day (OD). Spearman nonparametric correlation coefficients ( R ) were calculated, and variables proving to be significantly associated ( P < 0.1) were introduced into a linear regression model. The total consumption of macrolides presented a significant correlation with the prevalence of resistance ( R = 0.527; P = 0.032). Neither TID nor BID macrolide consumption showed significant correlations. Only OD consumption had a significance below 0.1. These data are consistent with the hypothesis that only the total consumption of macrolides influences the local rates of M-type erythromycin resistance in S. pyogenes, and subgroups of macrolides seem to have an additive rather than a selective effect by contributing to increasing the final amount of macrolides used. Local variations in total consumption were associated only with BID consumption ( R = 0.849; P = 0.004). The simple linear regression with total macrolide consumption showed a considerable determination coefficient ( R 2 = 0.678; P = 0.006). The model explains up to 68% of the measured variation and is clearly better as a predictor of the prevalence of resistance than the mere mean is. By solving the regression equation, the resultant value of 2.2 defined doses per 1,000 inhabitants per day fits with the existence of a critical threshold of selective pressure.Keywords
This publication has 35 references indexed in Scilit:
- Influence of Recombination and Niche Separation on the Population Genetic Structure of the Pathogen Streptococcus pyogenesInfection and Immunity, 2002
- The Relationship between Antimicrobial Use and Antimicrobial Resistance in EuropeEmerging Infectious Diseases, 2002
- Importance of Local Variations in Antibiotic Consumption and Geographical Differences of Erythromycin and Penicillin Resistance in Streptococcus pneumoniaeJournal of Clinical Microbiology, 2002
- Antimicrobial Susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes Isolates and Their Ecological Relationships: Results of a 1-Year (1998–1999) Multicenter Surveillance Study in SpainAntimicrobial Agents and Chemotherapy, 2001
- Multilocus Sequence Typing ofStreptococcus pyogenesand the Relationships betweenemmType and CloneInfection and Immunity, 2001
- Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibioticsThe Pediatric Infectious Disease Journal, 2000
- Genetic Linkage of Exotoxin Alleles andemmGene Markers for Tissue Tropism in Group A StreptococciThe Journal of Infectious Diseases, 1999
- Resistance ofStreptococcus pyogenesto Erythromycin and Related Antibiotics in ItalyClinical Infectious Diseases, 1998
- The resurgence of group A streptococcal infections and their sequelaeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- THE SENSITIVITY OF STAPHYLOCOCCI AND OTHER WOUND BACTERIA TO ERYTHROMYCIN, OLEANDOMYCIN, AND SPIRAMYCINJournal of Clinical Pathology, 1959